Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
GEHC · NASDAQ · Health Care Equipment
GE HealthCare (GEHC) · oqro.io/stocks/GEHC · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
$80.64−1.25 (−1.53%)
Close of Nov 20, 2026, vs Nov 19 · end-of-day
No open-market purchase by an insider of GE HealthCare was filed in the last 90 days. The latest on record was on May 26, 2026.
Since 2023, GE HealthCare insiders reported 10 open-market purchases and 13 sales on Forms 4 and 5, with purchases in 3 different years, most recently 2026.
No open-market sale by an insider of GE HealthCare (GEHC) was filed with the SEC in the last 90 days.
Yes. Members of Congress disclosed 3 trades in GE HealthCare (GEHC) in the last 12 months, each reported as a value range on a periodic transaction report. The most recent are from Sen. Alan Armstrong, Rep. Terri A. Sewell (AL07), Rep. Warren Davidson (OH08).
GE HealthCare's next results are expected on Feb 8, 2027, before the market opens. The date can move until the company confirms it. Insiders often trade in the weeks right after results.
From official filings only: SEC Forms 4, 5 and 144 for insiders, House and Senate periodic transaction reports for Congress, SEC Form 13F for funds, Form 8-K for company events and USAspending for federal contracts. Every record on OQRO links to its source. It is public data, not investment advice.
+7.9% (+$5.89) from Nov 20, 2025 to Nov 20, 2026 · adjusted daily closes
Adjusted close went from $74.75 on Nov 20, 2025 to $80.64 on Nov 20, 2026 (+7.9%). Disclosed in this range: 8 insider trades, 0 pre-arranged insider sales, 3 Congress trades, and 85 13F position changes for 4 quarters ending in it.
Counts of filings OQRO holds, by the date each was filed or the award started. Every figure links to its official SEC, House, Senate or USAspending record.
Health Care Equipment company based in Chicago, Illinois.
Last 12 months
+7.9%
Market value
$36.5B
S&P 500 +5.7% over the same dates. Prices adjusted for splits and dividends.
Short interest: 18.3M shares sold short (4.0% of shares outstanding), −5.8% vs the previous count, 4.9 days of normal trading to buy them back. FINRA, as of Oct 30, 2026. Short interest history
Revenue, fiscal 2025
$20.6B
+4.8% vs the year before
Net income, fiscal 2025
$2.08B
As reported in the annual filing
Shares outstanding
452M
As of Oct 21, 2026
In fiscal 2025 the company spent $200M buying back its own shares and $64M on dividends. Cash actually paid, from its cash-flow statement.
Last dividend: $0.04 a share (quarterly), ex-date Oct 23, 2026, paid Nov 13, 2026. Calendar
Fund moves
From a 13F filed Nov 16, 2026 covering holdings at Sep 30, 2026 — a quarter-end snapshot, not a live trade.
James Saccaro (Officer) plans to sell ~$6.73M of GE HealthCare
Fund moves
11 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
28 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Fund moves
53 tracked managers disclosed the same change for Q2 2026. From a 13F filed Aug 14, 2026 covering holdings at Jun 30, 2026 — a quarter-end snapshot, not a live trade.
Prices are daily closes from Polygon.io. Company figures come from its own SEC filings. Past moves are not a forecast. OQRO reports what was filed and never tells you what to buy or sell.
Against the S&P 500 over the year
Since Nov 19, 2025, GEHC is up 11.5% and the index fund is up 4.1%: 7 points ahead of the market. Traders call a stock that beats the index over a period a relative-strength leader.
How much GEHC moves
Beta 0.7 (1 year vs SPY)
End-of-day prices. These figures describe the past year and say nothing about what comes next. Beta: how much the stock moved, on average, for each 1% move of the S&P 500 fund over 251 trading days (1 = in step with it).
On the public record for GE HealthCare over the 12 months to Nov 21, 2026: 86 FDA records (6th most among listed companies), 3 executive contributions and 4 clinical trials.
Insiders of GE HealthCare reported 10 open-market purchases and 13 sales since 2023; purchases in 3 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $6.42M8×8 trades | — |
| 2025 | — | $185K1×1 trade |
| 2024 | $101K1×1 trade | $9.56M7×7 trades |
| 2023 | $52K1×1 trade | $6.89M5×5 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Dodge & Cox
13G · passive · Up from 8.3% · 47.3M shares · filed Aug 7, 2026
Vanguard Capital Management
13G · passive · Crossed 5% · 33.4M shares · filed Apr 29, 2026
Recent moves
Dodge & Cox raised its stake to 10.5% from 8.3% · Schedule 13G, 2026
Dodge & Cox raised its stake to 8.3% from 6.9% · Schedule 13G, 2026
Capital Research Global Investors fell below 5% (4.6%) · Schedule 13G, 2026
Vanguard Capital Management went above 5%, with 7.31% · Schedule 13G, 2026
The Vanguard Group fell below 5% (0%) · Schedule 13G, 2026
Capital Research Global Investors went above 5%, with 5.5% · Schedule 13G, 2025
Source: SEC Schedules 13D and 13G, which anyone owning more than 5% of a class of stock must file. A 13D filer may seek to influence the company; a 13G filer is passive. Filings before December 2024 are free text and read from their cover page: a percent or share count that is not stated plainly is left blank. Each line links to the filing.
Top officer leaving
“On October 22, 2026, Jeannette Bankes notified GE HealthCare that she will resign as President and CEO, Patient Care Solutions.”
8-K on sec.govTop officer leaving
“Grogan’s offer letter provides for an annual base salary of $900,000, target annual bonus opportunity equal to 100% of base salary, an annual long-term incentive (“LTI”) award with a target grant date value of $3,300,000, and participation in GE HealthCare’s benefit plans, including its Retirement Savings Plan, Restoration Plan, and US Severance and Change in Control Plan for CEO and Leadership Te”
8-K on sec.govTop officer leaving
“(Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.”
8-K on sec.govFrom the company's 8-K, 10-K and 10-Q filings over the last two years. A flag is a reason to read the filing, not a verdict: many departures are planned retirements and many listing notices are resolved. Insider sales are shown for timing only; they are separate filings.
Written by OQRO's software from the last 12 months on record · Nov 19, 2026
Every number, name, date and link in the text above comes from this list; software checks that before the text is stored. This text was assembled directly from the facts, without a language model.
Insiders
Congress
Funds and stakes
Contracts, lobbying and filings
2 active phase 3 trials and 2 active phase 2 trials led by this company, mostly in myocardial ischemia, cognitive dysfunction, known or highly suspected central nervous system (cns) lesion. The ones with the nearest registered primary completion date still ahead:
Company reports, price and press
Who holds it
Things to keep in mind
Records
Source: ClinicalTrials.gov, studies whose lead sponsor is the company or a listed subsidiary. “Primary completion” is the sponsor's own registry date for the last main data collection. It is not an approval date, it says nothing about the result, and it is often revised.
Revenue
$5.51B
+7.2% vs the same quarter a year earlier
Free cash flow, last 12 months
$1.89B
This quarter $793M, a year earlier $483M
Net debt
$7.15B
Debt $9.97B, cash $2.83B, at Sep 30, 2026
Backlog
$16.1B
Work contracted but not yet delivered, as the company reports it
From the company's own quarterly and annual reports to the SEC. Free cash flow (cash from operations minus capital spending), net debt (debt minus cash) and 12-month totals are calculated by OQRO. Production rates, deliveries, approvals and guidance are in its results announcement of Oct 28, 2026.
Revenue and earnings history, 5 fiscal yearsEarnings dates and the stock's moves
7 certified in FY2026 Q3, vs 17 a year earlier. 7 positions in total, median offered wage $165K a year.
Labor condition applications for H-1B workers certified by the Department of Labor, counted by decision date (FY2026 Q3: Apr 1, 2026 to Jun 30, 2026, the latest quarter published). A certified application is a step before a visa petition, not a hire or a visa, and one application can cover several positions. Matched by employer ID number or name.
The three months Jul 1, 2026 to Sep 30, 2026, compared with the same quarter a year earlier, from the quarterly report filed Oct 28, 2026. Quarterly reports are not audited. Read the filing
+6.1% on the same quarter a year earlier ($3.65B)
+13% on the same quarter a year earlier ($749M)
+8.5% on the same quarter a year earlier ($731M)
+6.7% on the same quarter a year earlier ($3.38B)
+8.0% on the same quarter a year earlier ($1.77B)
Fiscal year Jan 1, 2025 to Dec 31, 2025, from the annual report filed Feb 4, 2026. Read the filing
+4.4% on the year before ($8.86B)
+4.3% on the year before ($5.13B)
−1.2% on the year before ($3.13B)
+16% on the year before ($2.51B)
Every annual report has a section where the company's managers explain the year's results (Item 7, Management's discussion and analysis). In this report it runs to about 8,000 words.
GE HealthCare’s operations are organized and managed through four reportable segments: Imaging, Advanced Visualization Solutions (“AVS”), Patient Care Solutions (“PCS”), and Pharmaceutical Diagnostics (“PDx”), and we assessed their performance using Segment revenues and Segment EBIT. For additional information on the nature of our business and our segments, refer to Item 1, “Business” and Note 4, “Segment and Geographical Information.” On January 3, 2023, General Electric Company, which now operates as GE Aerospace (“GE”), completed the spin-off of GE HealthCare Technologies Inc. (the “Spin-Off”). Refer to Note 19, “Related Parties and Transition Services Agreement” for further information.
Source: SEC EDGAR, Form 10-K filed Feb 4, 2026 and Form 10-Q filed Oct 28, 2026. Revenue lines are the figures the company tags in its filing; OQRO shows a split only when its lines add up to the reported total revenue. The quote is the opening of the managers' discussion, cut at a sentence; the word count is estimated from its length. Not investment advice.
+4.5% on the year before ($13.1B)
+5.6% on the year before ($6.6B)
+5.7% on the year before ($8.92B)
+6.4% on the year before ($8.62B)
−4.9% on the year before ($2.13B)
And 13 more headings in the filing.
Latest annual report filed Feb 4, 2026, compared with the one filed Feb 13, 2025. Read the filing
Information on material pending legal proceedings is incorporated herein by reference to the information set forth in Note 14, “Commitments, Guarantees, Product Warranties, and Other Loss Contingencies” to the financial statements included elsewhere in this Annual Report on Form 10-K.
The company describes its cases in the notes to its financial statements, in the same filing.
Source: SEC EDGAR, Form 10-K filed Feb 4, 2026. Headings are the titles the company gives each risk; OQRO compares them with the year before by their words, so a heading that was reworded a lot shows up as both new and no longer listed. Companies list the risks they face, not forecasts.
Last results
Oct 28, 2026
Within the 30 days after it, until Nov 27, 2026
Next results, expected
Feb 8, 2027
before the market opens; the date can move until the company confirms it
Purchases after results
100%
10 of 10 insider purchases since 2023 came within 30 days after a results announcement
From GE HealthCare's own results filings (8-K Item 2.02) and its insiders' Forms 4 and 5. Many companies only let insiders trade in a period after results; OQRO does not know GE HealthCare's policy and only shows the pattern in the filings. A purchase made long after results, at a company whose insiders usually buy right after them, is marked “Bought outside the usual window”.
31 approvals or clearances and 56 recalls recorded by the FDA for this company and its listed subsidiaries.
From openFDA: Drugs@FDA (new applications and new uses), device 510(k) and PMA decisions, and FDA enforcement reports. Class I recalls are the most serious, Class III the least. Most recalls are started by the company itself. Labeling and manufacturing changes are not listed.
Short sale volume: 47.9% of the volume reported to FINRA over the last 20 trading days was marked short, below its 1-year average of 53.9%. FINRA daily files, to Nov 20, 2026.
Fails to deliver: 70K shares (about $4.98M) were not delivered on time for settlement on Oct 28, 2026. SEC fails-to-deliver data.
Short sale volume is not short interest. It counts trades marked short, including market makers selling short to fill buy orders, so it is a share of daily trading, not a count of bets against the stock. Fails to deliver have many causes, including processing delays, and are often resolved within days.
Off-exchange trading: 41.2% of the shares traded over the latest 4 published weeks changed hands away from the exchanges (26.6% on ATS, 14.6% with other brokers), close to its 26-week average of 42.6%. Weeks of Oct 5 to Oct 30, 2026.
Largest ATS: UBS ATS (14.3%), INTELLIGENT CROSS LLC (11.3%), LEVEL ATS (10.2%), as a share of this stock's ATS volume over the same 4 weeks.
An ATS, often called a dark pool, is a private trading venue run by a broker where orders are not shown publicly before they trade. Other off-exchange trades are mostly retail orders filled by wholesale brokers. A high share is common and says nothing by itself about where the price goes. FINRA OTC Transparency data, published 2 weeks after each week for the largest stocks and 4 weeks for others; total volume from our daily price data.